Myron Z. Holubiak's most recent trade in Citius Oncology Inc. was a trade of 850,000 Common Stock done . Disclosure was reported to the exchange on Sept. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Citius Oncology Inc | Myron Z. Holubiak | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 850,000 | 850,000 | - | 0 | Common Stock | |
| Citius Oncology Inc | Myron Z. Holubiak | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 850,000 | 850,000 | - | 0 | Common Stock | |
| Citius Oncology Inc | Myron Z. Holubiak | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 850,000 | 850,000 | - | 0 | Common Stock | |
| Citius Oncology Inc | Myron Z. Holubiak | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2025 | 100,000 | 100,000 | - | 0 | Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Aug 2025 | 31,373 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2025 | 31,373 | 31,373 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 08 Aug 2025 | 22,344 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2025 | 22,344 | 22,344 | - | - | Warrant to Purchase Common Stock | |
| Citius Oncology Inc | Myron Z. Holubiak | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Citius Oncology Inc | Myron Z. Holubiak | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 350,000 | 350,000 | - | - | Stock Option (Right to Purchase Common Stock) | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 784,314 | 784,314 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2024 | 784,314 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 558,597 | 558,597 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2024 | 558,597 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Oncology Inc | Myron Z. Holubiak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 1,500,000 | 1,500,000 | - | - | Stock Option (Right to Buy) | |
| Citius Oncology Inc | Myron Z. Holubiak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Apr 2024 | 129,450 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2024 | 129,450 | 129,450 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 400,000 | 400,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2021 | 650,000 | 650,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2021 | 15,000 | 15,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 300,000 | 300,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharma Inc | Myron Z. Holubiak | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | |
| Assembly Biosciences Inc | Myron Z. Holubiak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |